Following the PRECISION trial, prostate multiparametric MRI has been adopted as the first-line investigation for suspected ...
Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.
A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to ...
A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.
In a phase 3 trial, participants with higher-grade prostate cancer saw oncologic benefits from extended lymph node dissection during radical prostatectomy. Extended pelvic lymph node dissection (ePLND ...
Artificial intelligence (AI) has shown promise for diagnosing prostate cancer in biopsies. However, results have been limited to individual studies, lacking validation in multinational settings.
The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer.
A joint consultation of experts from the Genitourinary Pathology Society (GUPS) and the International Society of Urological Pathology (ISUP) recently clarified guidance for the diagnosis, terminology, ...
Decipher genomic classifier scores combined with Gleason grade group improve risk stratification for prostate cancer patients on active surveillance. Patients with GG1 and high genomic classifier ...
The aggressiveness of prostate cancer is primarily assessed from histopathological data using the Gleason scoring system. Conventional artificial intelligence (AI) approaches can predict Gleason ...
Two men have low-grade prostate cancer, limited Gleason 3+3 disease, and both are good candidates for active surveillance (AS). But their risk may not be the same, a new Brady study has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results